Safety and Efficacy of Segmental Yttrium-90 Radioembolization for Hepatocellular Carcinoma after Transjugular Intrahepatic Portosystemic Shunt Creation
To evaluate safety and efficacy of segmental yttrium-90 (Y90) radioembolization for hepatocellular carcinoma (HCC) after transjugular intrahepatic portosystemic shunt (TIPS) placement. The hypothesis was liver sparing segmental Y90 for HCC after TIPS would provide high antitumor response with a tolerable safety profile.
Source: Journal of Vascular and Interventional Radiology : JVIR - Category: Radiology Authors: Andrew C. Gordon, Aakash N. Gupta, Ahmed Gabr, Bartley G. Thornburg, Laura M. Kulik, Daniel R. Ganger, Haripriya Maddur, Steven L. Flamm, Justin R. Boike, Christopher M. Moore, Daniel Borja-Cacho, Derrick A. Christopher, Nitin N. Katariya, Daniela P. Ladn Tags: Clinical Study Source Type: research
More News: Cancer & Oncology | Carcinoma | Hepatocellular Carcinoma | Liver | Liver Cancer | Radiology | Study | Urology & Nephrology